Where is Alder BioPharmaceuticals headquartered?

Alder BioPharmaceuticals is located in Bothell, WA.

Who invested in Alder BioPharmaceuticals?

Alder BioPharmaceuticals has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Alder BioPharmaceuticals raised to date?

Alder BioPharmaceuticals has raised ____.

When was the last funding round for Alder BioPharmaceuticals?

Alder BioPharmaceuticals closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

alderbio.com

Alder BioPharmaceuticals

Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine.

Business Model:

Revenue: $6.5M

Employees: 201-500

Alder BioPharmaceuticals was acquired by Lundbeck.
The acquisition happend on 2019-09-16.
Details of the transaction were not public

Acquirer

Lundbeck

General Information

Geographic Data

Alder BioPharmaceuticals headquarters map

Address: 11804 North Creek Parkway South

City: Bothell

State: WA

Zip: 98011

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$170M

Raised Total:

$525M

Social

Facebook

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine.

Contact Phone:
+14252052900

Contact Email:

IPO Details

Alder BioPharmaceuticals went public on 5/8/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/8/2014

IPO Valuation:
$407M

Ticker Symbol:
ALDR

IPO Price:
$45.5/share

Amount Raised:
$200M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
7/2006	Series B	5	$16M	H.I.G. Capital WRF Capital Washington Research Foundation Ventures West Sevin Rosen Funds H.I.G. Capital
4/2012	Series D		$0	Sevin Rosen Funds TPG Biotech Novo Ventures Delphi Ventures Ventures West H.I.G. Capital Washington Research Foundation Novo Ventures Sevin Rosen Funds TPG Biotech Novo Ventures Delphi Ventures Ventures West H.I.G. Capital Washington Research Foundation Novo Ventures
12/2007	Series C	2	$40M	TPG Biotech Delphi Ventures Delphi Ventures TPG Biotech TPG Biotech Delphi Ventures Delphi Ventures TPG Biotech
7/2005	Series A	3	$11M	Sevin Rosen Funds Washington Research Foundation Ventures West Sevin Rosen Funds
5/2014	IPO		$80M
6/2015	Secondary Offering		$200M
1/2018	Equity		$100M
4/2016	Secondary Offering		$125M
4/2019	Post-IPO Equity		$170M
1/2018	Post-IPO Equity	1	$250M	Redmile Group Redmile Group
4/2012	Series D	7	$38M	Novo Ventures TPG Biotech Delphi Ventures Sevin Rosen Funds Ventures West WRF Capital Sevin Rosen Funds TPG Biotech Novo Ventures Delphi Ventures Ventures West H.I.G. Capital Washington Research Foundation Novo Ventures

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details